Myklebust MP - Search Results

1

Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.

Myklebust MP, Fluge Ø, Immervoll H, Skarstein A, Balteskard L, Bruland O, Dahl O. Myklebust MP, et al. Br J Cancer. 2012 Feb 14;106(4):756-62. doi: 10.1038/bjc.2011.548. Br J Cancer. 2012. PMID: 22333708 Free PMC article.

2

MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer.

Myklebust MP, Bruland O, Fluge Ø, Skarstein A, Balteskard L, Dahl O. Myklebust MP, et al. Br J Cancer. 2011 Nov 22;105(11):1719-25. doi: 10.1038/bjc.2011.457. Epub 2011 Nov 1. Br J Cancer. 2011. PMID: 22045185 Free PMC article.

3

Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.

Myklebust MP, Li Z, Tran TH, Rui H, Knudsen ES, Elsaleh H, Fluge Ø, Vonen B, Myrvold HE, Leh S, Tveit KM, Pestell RG, Dahl O. Myklebust MP, et al. Br J Cancer. 2012 Nov 6;107(10):1684-91. doi: 10.1038/bjc.2012.463. Epub 2012 Oct 25. Br J Cancer. 2012. PMID: 23099809 Free PMC article. Clinical Trial.

4

Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer.

Hestetun KE, Brydøy M, Myklebust MP, Dahl O. Hestetun KE, et al. Among authors: myklebust mp. Acta Oncol. 2015 Apr;54(4):470-9. doi: 10.3109/0284186X.2014.952386. Epub 2014 Sep 17. Acta Oncol. 2015. PMID: 25227897 Clinical Trial.

5

CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.

Stanisavljević L, Aßmus J, Storli KE, Leh SM, Dahl O, Myklebust MP. Stanisavljević L, et al. Among authors: myklebust mp. Tumour Biol. 2016 Jun;37(6):7441-52. doi: 10.1007/s13277-015-4591-8. Epub 2015 Dec 17. Tumour Biol. 2016. PMID: 26678887 Clinical Trial.

6

LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.

Stanisavljević L, Myklebust MP, Leh S, Dahl O. Stanisavljević L, et al. Among authors: myklebust mp. Acta Oncol. 2016 Dec;55(12):1425-1433. doi: 10.1080/0284186X.2016.1201215. Epub 2016 Jul 20. Acta Oncol. 2016. PMID: 27435662 Clinical Trial.

7

Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.

Jacob H, Stanisavljevic L, Storli KE, Hestetun KE, Dahl O, Myklebust MP. Jacob H, et al. Among authors: myklebust mp. Oncotarget. 2017 Sep 23;8(50):87837-87847. doi: 10.18632/oncotarget.21237. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152124 Free PMC article.

8

A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer.

Jacob H, Stanisavljevic L, Storli KE, Hestetun KE, Dahl O, Myklebust MP. Jacob H, et al. Among authors: myklebust mp. Sci Rep. 2018 Apr 18;8(1):6157. doi: 10.1038/s41598-018-24519-4. Sci Rep. 2018. PMID: 29670141 Free PMC article.

9

Quantitative PCR Measurement of miR-371a-3p and miR-372-p Is Influenced by Hemolysis.

Myklebust MP, Rosenlund B, Gjengstø P, Bercea BS, Karlsdottir Á, Brydøy M, Dahl O. Myklebust MP, et al. Front Genet. 2019 May 22;10:463. doi: 10.3389/fgene.2019.00463. eCollection 2019. Front Genet. 2019. PMID: 31191602 Free PMC article.

10

Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version.

Dahl O, Myklebust MP, Dale JE, Leon O, Serup-Hansen E, Jakobsen A, Pfeiffer P, Løes IM, Pfeffer F, Spindler KG, Guren MG, Glimelius B, Johnsson A. Dahl O, et al. Among authors: myklebust mp. Acta Oncol. 2020 Sep;59(9):1016-1023. doi: 10.1080/0284186X.2020.1778180. Epub 2020 Jun 23. Acta Oncol. 2020. PMID: 32574087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters